Emily’s Entourage Announces Addition of David M. Bedwell, PhD, to its Scientific Advisory Board
Dr. Bedwell joins seven other highly respected and experienced researchers, clinicians, and health industry leaders to provide guidance on strategic research priorities for the organization
David M. Bedwell, PhD, joins the Scientific Advisory Board for Emily’s Entourage
Lower Merion, PA — Sept. 12, 2022 — Emily’s Entourage (EE), an innovative 501(c)3 foundation that accelerates research for new treatments and a cure for the final 10% of people with cystic fibrosis (CF), including those with nonsense mutations, today announced the addition of David M. Bedwell, PhD, to its Scientific Advisory Board (SAB). EE’s SAB brings together top researchers, clinicians, and health industry leaders, including some of the most respected names in CF research and care.
Dr. Bedwell is the James C. and Elizabeth T. Lee Endowed Chair of Biochemistry and is professor and chair of the Department of Biochemistry and Molecular Genetics in the Heersink School of Medicine at the University of Alabama at Birmingham (UAB).
“Dr. Bedwell brings decades of expertise and leadership in key areas in cystic fibrosis research, as well as a palpable passion for the CF community at large,” said Chandra Ghose, PhD, Chief Scientific Officer at Emily’s Entourage. “We are thrilled to have him as an invaluable member of our SAB as we continue our work on expediting the research and development of therapeutics for patients with CF who do not benefit from current mutation-targeted treatments.”
Dr. Bedwell serves as the co-director of the UAB Structural Biology Program and as the interim director of the Gregory Fleming James Cystic Fibrosis Research Center. He is also an editorial board member for the Journal of Biological Chemistry.
“I’m delighted to be given the opportunity to join the team at Emily’s Entourage,” said Dr. Bedwell. “I have been impressed with their past accomplishments and I hope I can help them achieve many more in the coming years.”
Dr. Bedwell sits on the Scientific Advisory Board alongside the following members:
- Jennifer Bomberger, PhD
- Kevin Foskett, PhD (board chair)
- Denis Hadjiliadis, MD
- Batsheva Kerem, PhD
- Jennifer Taylor-Cousar, MD, MSCS, ATSF
- Ted J. Torphy, PhD
- David B. Weiner, PhD
###
About Emily’s Entourage
Emily’s Entourage is an innovative 501(c)3 foundation that accelerates research for new treatments and a cure for nonsense mutations of cystic fibrosis, a fatal genetic disease primarily afflicting the lungs and digestive system. Since 2011, Emily’s Entourage has awarded millions of dollars in research grants, launched a CF gene therapy company, developed a patient registry and clinical trial matchmaking program to accelerate clinical trial recruitment, and led worldwide efforts to drive high-impact research and drug development. The organization has been featured in national media, including the New York Times, STAT, CNN, People, and more. Learn more at emilysentourage.org.
Media Contact
Ashling Knight
Director of Marketing and Communications
Emily’s Entourage
ashling@emilysentourage.org
